Variables in demonstrating methicillin tolerance in Staphylococcus aureus strains.

Antimicrobial Agents and Chemotherapy
K IshidaL B Guze

Abstract

Certain technical considerations which affected the status of methicillin tolerance in Staphylococcus aureus strains were studied. Methods which consistently demonstrated tolerance or intolerance of a given strain were avoidance of inoculum splashing, use of stationary-phase inoculum, 24-h tube incubation, and minimization of antibiotic carry-over. These studies suggested a need for the establishment of a standardized reference for the determination of tolerance.

References

Feb 26, 1977·Lancet·L D SabathB J Wilkinson
Jun 1, 1978·Antimicrobial Agents and Chemotherapy·J J BradelyH P Dalton
Aug 1, 1979·Antimicrobial Agents and Chemotherapy·R H RaynorG K Best
Aug 1, 1979·Antimicrobial Agents and Chemotherapy·K S KimB F Anthony
Sep 1, 1979·Archives of Internal Medicine·A E DennyW H Hall
Apr 1, 1978·Antimicrobial Agents and Chemotherapy·L R PetersonE A Schierl
Aug 9, 1980·Lancet·M McDonaldN Sonenberg
Feb 1, 1980·The Journal of Infectious Diseases·H E BradleyD S Hodes
Jun 1, 1980·Antimicrobial Agents and Chemotherapy·D J Krogstad, A R Pargwette
Dec 1, 1980·Annals of Internal Medicine·K R RajashekaraiahC A Kallick
Nov 1, 1980·Antimicrobial Agents and Chemotherapy·R D PearsonS W Chapman

❮ Previous
Next ❯

Citations

Feb 1, 1986·European Journal of Clinical Microbiology·H C Standiford, B A Tatem
Apr 1, 1986·Diagnostic Microbiology and Infectious Disease·K KrasinskiD Desiderio
Oct 1, 1985·Zentralblatt Für Bakteriologie, Mikrobiologie, Und Hygiene. Series A, Medical Microbiology, Infectious Diseases, Virology, Parasitology·R Haag, R Hoffmann
Apr 11, 1985·The New England Journal of Medicine·J S Wolfson, M N Swartz
Nov 1, 1986·Antimicrobial Agents and Chemotherapy·J C Sherris
Mar 1, 1986·Antimicrobial Agents and Chemotherapy·P R MeylanM P Glauser
Sep 1, 1985·Antimicrobial Agents and Chemotherapy·B F WoolfreyM N Ederer
Sep 1, 1985·Antimicrobial Agents and Chemotherapy·S HolzhofferR Haag
Aug 1, 1984·Antimicrobial Agents and Chemotherapy·C J ShanholtzerD N Gerding
Feb 1, 1983·Antimicrobial Agents and Chemotherapy·J S VenglarcikL M Dunkle
Dec 1, 1984·Antimicrobial Agents and Chemotherapy·L L Pelletier
Sep 1, 1994·Antimicrobial Agents and Chemotherapy·C BetriuJ J Picazo
May 16, 2008·Journal of Clinical Microbiology·Nacer LounisKoen Andries
Apr 1, 1987·Diagnostic Microbiology and Infectious Disease·M E Gresser-BurnsD N Gerding
Jan 1, 1988·Scandinavian Journal of Infectious Diseases·B J Woolfrey
Apr 16, 2016·Nature Reviews. Microbiology·Asher BraunerNathalie Q Balaban
Feb 22, 2011·Comparative Biochemistry and Physiology. Part B, Biochemistry & Molecular Biology·Erika dos Santos NunesMaria Tereza dos Santos Correia
Apr 1, 1988·The Journal of Pediatrics·K S Kim
Jan 1, 1988·Clinical Microbiology Reviews·C W Stratton
Jun 1, 1986·Journal of Clinical Microbiology·B F WoolfreyK R Tait
Oct 1, 1992·Clinical Microbiology Reviews·L R Peterson, C J Shanholtzer

❮ Previous
Next ❯

Related Concepts

Related Feeds

CRISPR Screens in Drug Resistance

CRISPR-Cas system enables the editing of genes to create or correct mutations. This feed focuses on the application of CRISPR-Cas system in high-throughput genome-wide screens to identify genes that may confer drug resistance.

Antifungals

An antifungal, also known as an antimycotic medication, is a pharmaceutical fungicide or fungistatic used to treat and prevent mycosis such as athlete's foot, ringworm, candidiasis, cryptococcal meningitis, and others. Discover the latest research on antifungals here.

Antifungals (ASM)

An antifungal, also known as an antimycotic medication, is a pharmaceutical fungicide or fungistatic used to treat and prevent mycosis such as athlete's foot, ringworm, candidiasis, cryptococcal meningitis, and others. Discover the latest research on antifungals here.